🕵️ Guardian Pharmacy Services, Inc. ($GRDN)
SEC insider & ownership activity, last 12 months · CIK 1802255 · every row links its SEC filing
Over the last 12 months insiders sold $445.2M against $100K of open-market buying. William E. Bindley sold $106.0M in discretionary trades (Mar). Thomas J. Salentine, JR. trimmed 22.3% → 21.3%; William E. Bindley trimmed 22.2% → 21.2%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $100K (1 lots) · 9 sellers, $445.2M (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| William E. Bindley | 0 | – | 1 | $106.0M | Mar 20, 2026 |
| Bindley Capital Partners I, LLC | 0 | – | 1 | $106.0M | Mar 20, 2026 |
| Thomas J. Salentine Jr. | 0 | – | 1 | $106.0M | Mar 20, 2026 |
| Pharmacy Investors, LLC | 0 | – | 3 | $44.0M | Mar 20, 2026 |
| Ackerman John | 0 | – | 2 | $32.8M | Mar 20, 2026 |
| Burke Fred | 0 | – | 1 | $19.9M | Mar 20, 2026 |
| Cardinal Equity Fund, L.P. | 0 | – | 3 | $14.7M | Mar 20, 2026 |
| Forbes Kendall | 0 | – | 1 | $10.3M | Mar 20, 2026 |
| David K. Morris | 0 | – | 1 | $5.6M | Mar 20, 2026 |
| Steven D. Cosler | 1 | $100K | 0 | – | Dec 3, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Thomas J. Salentine, JR. | 21.3% | 13D | Mar 20, 2026 | filing ↗ | |
| William E. Bindley | 21.2% | 13D | Mar 20, 2026 | filing ↗ | |
| Bindley Capital Partners I, LLC | 21.2% | 13D | Mar 20, 2026 | filing ↗ | |
| Brown Advisory LLC | 17.1% | 13G | Jan 8, 2025 | filing ↗ | |
| FMR LLC | 6.5% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 6.5% | 13G | May 6, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Material agreement (1.01) | May 21, 2026 | filing ↗ |
| New financial obligation (2.03) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 18, 2026 | filing ↗ |
| Other events (8.01) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Other events (8.01) | Oct 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |